Multiple Waves of Roundup Lawsuit - Why Is It Still On Market?
In recent years, a growing number of individuals in the US, including farmers, landscapers, and agricultural workers, have been filing lawsuits against Monsanto and Bayer, alleging that their use of Roundup has led to the development of non-Hodgkin lymphoma. In 2020, Bayer offered a settlement amount of $10.9 billion to resolve thousands of these claims, while Roundup lawyers continue to handle new cases.
Given the potential link between Roundup and cancer, some may question why the herbicide is still available on the market. Judge Vince Chhabria shed some light on this issue in May 2021, stating that Bayer, as a large and prosperous company, continued to generate substantial revenue from Roundup sales. Around the same time, Bayer publicly expressed its commitment to resolving the Roundup litigation inherited from Monsanto. This stance was not surprising, considering that the alternative to settling would involve a continuous stream of unfavorable trial outcomes.
The main ingredient in Roundup, glyphosate, is primarily responsible for the concerns surrounding its potential to cause cancer. In 2015, the International Agency for Research on Cancer (IARC), a division of the World Health Organization (WHO), classified glyphosate as “probably carcinogenic to humans” after evaluating various studies involving humans, animals, and laboratory experiments. Numerous scientific investigations have reported an increased risk, ranging from 41% to 70%, of developing non-Hodgkin’s lymphoma with prolonged exposure to Roundup. Glyphosate can enter the body through skin contact, inhalation, or eye exposure, causing harm to the skin and potentially leading to non-Hodgkin’s lymphoma. Other diseases such as chronic lymphocytic leukemia (CLL) and certain subtypes of non-Hodgkin’s lymphoma have also been associated with glyphosate exposure.
It is important to note that the compensation awarded in Roundup lawsuits varies depending on individual circumstances, with the average payout falling within the range of $5,000 to $250,000. However, each lawsuit is unique, and outcomes can differ significantly.
The current landscape is not entirely favorable for the plaintiffs. Firstly, there are reports suggesting that Bayer may discontinue the sale of glyphosate-based herbicides for residential use in the US by 2023 to mitigate further litigation risks. Secondly, as of May 2023, Bayer has secured some victories in recent court decisions after facing significant initial losses in earlier cases.
Before it is too late to file a Roundup claim and get potential compensation, we encourage you to secure a spot for yourself or your loved ones. Our special hotline for a free Roundup case consultation is: (888) 819-2653.